OPKO Health
Active
6
7M
6
0.38
3
4
- Areas of investment
Summary
OPKO Health appeared to be the Corporate Investor, which was created in 2005. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Miami.
The common things for fund are deals in the range of 5 - 10 millions dollars. The higher amount of exits for fund were in 2018. The high activity for fund was in 2016. Comparing to the other companies, this OPKO Health performs on 46 percentage points more the average number of lead investments. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year.
The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Arno Therapeutics, VBI Vaccines, Eloxx Among the most popular fund investment industries, there are Health Care, Biopharma. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
This organization was formed by Phillip Frost.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the OPKO Health, startups are often financed by Pontifax, UTA Capital, Soros Fund Management. The meaningful sponsors for the fund in investment in the same round are Pontifax, Perceptive Advisors, Soros Fund Management. In the next rounds fund is usually obtained by Pontifax, Perceptive Advisors, Commercial Street Capital.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 3
- Exits
- 4
- Rounds per year
- 0.38
- Investments by industry
- Biotechnology (5)
- Health Care (3)
- Medical (2)
- Clinical Trials (1)
- Biopharma (1) Show 7 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Eloxx | 02 Aug 2017 | Biotechnology, Genetics | Late Stage Venture | 8M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.